Blue Jet Healthcare: ₹1,000 Crore Vizag Expansion, CDMO Growth & Margin Outlook | Business News
ET Now · 23 Sept 2026 · 26 min
Management interview of Blue Jet Healthcare Ltd (BLUEJET), with 5 key numbers discussed.
- V.K. Singh, COO, Blue Jet Healthcare Ltd
Blue Jet Healthcare reported that the destocking cycle in its pharma intermediate (PI) vertical is over and order momentum has revived. The company plans to deploy Rs 10bn over 24-30 months for Phase 1 of its Vizag expansion, which is part of a larger Rs 25bn commitment to Andhra Pradesh. Management stated that roughly 50% of the planned Vizag capacity is contractually committed with anchor clients in place. Operating margins are expected to be preserved in the mid-30s supported by operating leverage and contract pass-through clauses, while funding remains fully covered by QIP proceeds and internal accruals.